Chiang-ngernthanyakun K. Romosozumab: New anti-osteoporosis agent approved by food and drug administration of the United States. M Dent J [internet]. 2019 Dec. 26 [cited 2026 Sep. 28];39(3):181-97. available from: https://he02.tci-thaijo.org/index.php/mdentjournal/article/view/204508